PMID- 35975264 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220818 IS - 1841-0987 (Print) IS - 1843-066X (Electronic) IS - 1841-0987 (Linking) VI - 18 IP - 1 DP - 2022 Jan-Mar TI - STOP-BANG QUESTIONNAIRE - AN EASY TOOL FOR IDENTIFYING OBSTRUCTIVE SLEEP APNEA SYNDROME IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. PG - 49-57 LID - 10.4183/aeb.2022.49 [doi] AB - BACKGROUND: Patients with type 2 diabetes mellitus (T2DM) have a higher risk of developing obstructive sleep apnea (OSA) compared to the general population. Our study aims to analyze the usefulness of the STOP-BANG score, tool which was not yet validated in patients with diabetets, as a tool that estimates the severity of OSA, in patients with T2DM. METHODS: 120 patients, who answered the STOP-BANG questionnaire and underwent polysomnography, were included in the study. The patients were divided into 3 groups, depending on the severity of OSA, defined by the apnea/hypopnea index (AHI). RESULTS: A significant percentage of participants (42.1%) had a severe form of OSA (AHI >/=30) and a high percentage of subjects had a STOP-BANG score >/=5 (58.7%), equivalent to a severe form of the disease. The STOP-BANG score increased proportionally with AHI (p<0.001). The area under the ROC curve for the STOP-Bang score indicated an optimal cut-off value of 4.5, with a sensitivity of 88.2% and a specificity of 62.9% (p <0.001), STOP-BANG score >/=5 being an independent predictor for severe OSA in patients with T2DM. CONCLUSIONS: The STOP-BANG score can be used in patients with diabetes to detect severe OSA in order to establish appropriate therapeutic measures. CI - (c)2021 Acta Endocrinologica (Buc). FAU - Timofticiuc, D C Protasiewicz AU - Timofticiuc DCP AD - University of Medicine and Pharmacy of Craiova, Doctoral School, Craiova, Romania. AD - County Clinical Emergency Hospital of Craiova, Department of Diabetes, Nutrition and Metabolic Diseases, Craiova, Romania. FAU - Vladu, I M AU - Vladu IM AD - County Clinical Emergency Hospital of Craiova, Department of Diabetes, Nutrition and Metabolic Diseases, Craiova, Romania. AD - University of Medicine and Pharmacy of Craiova, Department of Diabetes, Nutrition and Metabolic Diseases, Faculty of Medicine, Craiova, Craiova, Romania. FAU - Stefan, A G AU - Stefan AG AD - Calafat Municipal Hospital, Calafat, Craiova, Romania. FAU - Fortofoiu, M C AU - Fortofoiu MC AD - University of Medicine and Pharmacy of Craiova, Faculty of Medicine, Department of Medical Semiology, Craiova, Romania. AD - Clinical Municipal Hospital "Philanthropy" of Craiova, Department of Internal Medicine, Craiova, Romania. FAU - Mitrea, A AU - Mitrea A AD - University of Medicine and Pharmacy of Craiova, Department of Diabetes, Nutrition and Metabolic Diseases, Faculty of Medicine, Craiova, Craiova, Romania. AD - Clinical Municipal Hospital "Philanthropy" of Craiova, Department of Diabetes, Nutrition and Metabolic Diseases, Craiova, Romania. FAU - Fortofoiu, M AU - Fortofoiu M AD - University of Medicine and Pharmacy of Craiova, Faculty of Medicine, Department of Emergency Medicine, Craiova, Romania. AD - Clinical Municipal Hospital "Philanthropy" of Craiova, Department of Emergency, Craiova, Romania. FAU - Mota, M AU - Mota M AD - University of Medicine and Pharmacy of Craiova, Doctoral School, Craiova, Romania. LA - eng PT - Journal Article PL - Romania TA - Acta Endocrinol (Buchar) JT - Acta endocrinologica (Bucharest, Romania : 2005) JID - 101269720 PMC - PMC9365405 OTO - NOTNLM OT - STOP-BANG score OT - obstructive sleep apnea OT - polysomnography OT - type 2 diabetes mellitus COIS- The authors declare that they have no conflict of interest. EDAT- 2022/08/18 06:00 MHDA- 2022/08/18 06:01 PMCR- 2022/07/01 CRDT- 2022/08/17 02:03 PHST- 2022/08/17 02:03 [entrez] PHST- 2022/08/18 06:00 [pubmed] PHST- 2022/08/18 06:01 [medline] PHST- 2022/07/01 00:00 [pmc-release] AID - aeb.2022.049 [pii] AID - 10.4183/aeb.2022.49 [doi] PST - ppublish SO - Acta Endocrinol (Buchar). 2022 Jan-Mar;18(1):49-57. doi: 10.4183/aeb.2022.49.